MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
19.43
-0.35 (-1.77%)
At close: Jun 18, 2025, 4:00 PM
19.39
-0.04 (-0.21%)
After-hours: Jun 18, 2025, 5:53 PM EDT
MediWound Stock Forecast
Stock Price Forecast
The 2 analysts that cover MediWound stock have a consensus rating of "Strong Buy" and an average price target of $35, which forecasts a 80.13% increase in the stock price over the next year. The lowest target is $31 and the highest is $39.
Price Target: $35 (+80.13%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MediWound stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $31 | Strong Buy | Maintains | $25 → $31 | +59.55% | May 22, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +28.67% | Mar 20, 2025 |
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +100.72% | Feb 28, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +28.67% | Jan 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +28.67% | Nov 27, 2024 |
Financial Forecast
Revenue This Year
24.43M
from 20.22M
Increased by 20.80%
Revenue Next Year
31.01M
from 24.43M
Increased by 26.92%
EPS This Year
-2.42
from -3.03
EPS Next Year
-2.48
from -2.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 27.2M | 35.1M | 50.6M | ||
Avg | 24.4M | 31.0M | 39.4M | ||
Low | 21.6M | 25.9M | 32.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 34.4% | 43.7% | 63.2% | ||
Avg | 20.8% | 26.9% | 26.9% | ||
Low | 6.9% | 6.1% | 5.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.35 | -1.92 | -1.22 | ||
Avg | -2.42 | -2.48 | -2.07 | ||
Low | -2.90 | -3.14 | -2.79 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.